We are live on
!
Find out more
1CM
1492 Capital Management Portfolio holdings
AUM
$263M
1-Year Est. Return
61.9%
This Fund
S&P 500
This Quarter
Est. Return
+19.01%
1 Year Est. Return
+61.9%
3 Year Est. Return
+187.15%
5 Year Est. Return
+242.53%
10 Year Est. Return
+2,731.07%
AUM
$155M
AUM Growth
+$16.2M
(+12%)
Cap. Flow
+$2.54M
Cap. Flow
% of AUM
1.64%
Top 10 Holdings %
Top 10 Hldgs %
34.48%
Holding
127
New
21
Increased
20
Reduced
41
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DocGo
DCGO
|
+$4.43M |
| 2 |
OmniAb
OABI
|
+$2.33M |
| 3 |
Zeta Global
ZETA
|
+$2.23M |
| 4 |
QuidelOrtho
QDEL
|
+$2.09M |
| 5 |
EXAS
Exact Sciences
EXAS
|
+$2.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lumentum
LITE
|
+$4.3M |
| 2 |
Semtech
SMTC
|
+$2.23M |
| 3 |
BMTX
BM Technologies, Inc.
BMTX
|
+$2.14M |
| 4 |
SKX
Skechers
SKX
|
+$2.03M |
| 5 |
Graphic Packaging
GPK
|
+$1.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.99% |
| 2 | Technology | 19.93% |
| 3 | Industrials | 10.66% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Energy | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $13.5M | 8.67% |
118,225
-1,611
| -1% | -$134K |
|
|
ROCC
2
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $5.36M | 3.45% |
132,511
+16,967
| +15% | +$672K |
|
3
Copa Holdings
CPA
$5.56B
| $4.94M | 3.19% |
59,444
-385
| -0.6% | -$30.3K |
|
4
Perion Network
PERI
$367M
| $4.79M | 3.09% |
189,270
-2,402
| -1% | -$58.5K |
|
|
5
DocGo
DCGO
$58.9M
| $4.48M | 2.89% |
634,301
+528,413
| +499% | +$4.43M |
|
6
Sterling Infrastructure
STRL
$20.3B
| $4.46M | 2.87% |
135,922
-1,313
| -1% | -$38.6K |
|
7
A10 Networks
ATEN
$2.47B
| $4.17M | 2.69% |
250,559
-2,202
| -0.9% | -$37.7K |
|
|
8
Zeta Global
ZETA
$4.77B
| $4.04M | 2.61% |
494,977
+274,626
| +125% | +$2.23M |
|
9
Darling Ingredients
DAR
$9.93B
| $3.91M | 2.52% |
62,511
-973
| -2% | -$68.6K |
|
10
Adtran
ADTN
$798M
| $3.86M | 2.49% |
205,659
-2,386
| -1% | -$47.9K |
|
11
Carpenter Technology
CRS
$30B
| $3.82M | 2.47% |
103,523
-745
| -0.7% | -$28.4K |
|
12
SM Energy
SM
$7.96B
| $3.7M | 2.39% |
106,280
+40,981
| +63% | +$1.7M |
|
13
MaxLinear
MXL
$6.49B
| $3.7M | 2.38% |
108,819
-3,199
| -3% | -$108K |
|
|
14
QuidelOrtho
QDEL
$1.09B
| $3.66M | 2.36% |
42,740
+24,676
| +137% | +$2.09M |
|
15
Accel Entertainment
ACEL
$979M
| $3.01M | 1.94% |
391,314
-23,120
| -6% | -$199K |
|
|
VBTX
16
DELISTED
Veritex Holdings
VBTX
| $2.95M | 1.9% |
105,144
-10,819
| -9% | -$321K |
|
|
LTHM
17
DELISTED
Livent Corporation
LTHM
| $2.87M | 1.85% |
144,628
-59
| -0% | -$1.61K |
|
18
MannKind Corp
MNKD
$1.28B
| $2.83M | 1.83% |
537,830
-8,880
| -2% | -$36.4K |
|
19
Caesars Entertainment
CZR
$6.1B
| $2.74M | 1.77% |
65,831
-2,139
| -3% | -$95.2K |
|
20
Arcutis Biotherapeutics
ARQT
$3.42B
| $2.58M | 1.67% |
174,546
-3,774
| -2% | -$65.9K |
|
|
EXAS
21
DELISTED
Exact Sciences
EXAS
| $2.51M | 1.62% |
+50,775
| New | +$2.07M |
|
22
CACI
CACI
$10.8B
| $2.22M | 1.43% |
7,371
-2,524
| -26% | -$736K |
|
|
XM
23
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $2.08M | 1.34% |
200,753
-1,242
| -0.6% | -$13K |
|
24
RingCentral
RNG
$4.05B
| $2.06M | 1.33% |
58,204
-1,400
| -2% | -$50.1K |
|
|
PWSC
25
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $1.92M | 1.24% |
83,192
| – | – |
|
Similar funds
KA
LCGC
DEA
EAN
PIP
VIG
SC
L
1492 Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, 1492 Capital Management held 127 positions worth $155M, up 12% from $139M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
1492 Capital Management's Q4 2022 filing shows 21 new, 20 increased, 41 reduced and 23 closed positions. Its largest new stake was OmniAb: 443,484 shares worth $1.6M. The largest sale was Lumentum, an estimated $4.3M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.
- 1492 Capital Management's largest Q4 2022 buy was OmniAb: 443,484 shares worth $1.6M.
- 1492 Capital Management added most to DocGo in Q4 2022, an estimated $4.43M increase.
- 1492 Capital Management's biggest Q4 2022 reduction was Skechers, cutting an estimated $2.03M.
- 1492 Capital Management fully exited Lumentum in Q4 2022, selling an estimated $4.3M.
- 1492 Capital Management's ten largest holdings make up 34% of its $155M portfolio in Q4 2022.
- 1492 Capital Management opened 21 new positions and closed 23 in Q4 2022.
- 1492 Capital Management's portfolio value rose 12% quarter-over-quarter to $155M.
Based on 1492 Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.